Cargando…

Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become a public health emergency of international concern. SARS-CoV-2 RNA detection is the diagnostic criterion for coronavirus disease 2019 (COVID-19). Nevertheless, RNA detection has many limitations, such as be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Jialin, Chen, Zuyi, Zhou, Jie, Tian, Di, Ran, Xiusheng, Zhang, Zhimin, Shi, Shi, Xiao, Daimin, Zhou, Yuanzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573872/ https://www.ncbi.nlm.nih.gov/pubmed/33081702 http://dx.doi.org/10.1186/s12879-020-05489-3

Ejemplares similares

HAEMATOLOGY IN DIAGNOSIS AND TREATMENT
Publicado: (1969)

Practical Hæmatological Diagnosis
Publicado: (1933)

AN INDEX OF DIFFERENTIAL DIAGNOSIS OF MAIN SYMPTOMS
Publicado: (1945)

An Index of Differential Diagnosis of Main Symptoms
Publicado: (1936)

An Index of Differential Diagnosis of Main Symptoms
Publicado: (1917)

An Index of Differential Diagnosis of Main Symptoms
Publicado: (1913)

An Index of Differential Diagnosis of Main Symptoms
Publicado: (1945)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

Advances in the application of Raman spectroscopy in haematological tumours
por: Liang, Haoyue, et al.
Publicado: (2023)

Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit – High mortality rate in infected patients with haematologic malignancies
por: Biernat, Monika M, et al.
Publicado: (2020)

An application of machine learning to haematological diagnosis
por: Gunčar, Gregor, et al.
Publicado: (2018)

An extended conformation of SARS-CoV-2 main protease reveals allosteric targets
por: Sun, Zengchao, et al.
Publicado: (2022)

Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases
por: Otiniano, Armelle, et al.
Publicado: (2022)

Structure of SARS-CoV-2 main protease in the apo state
por: Zhou, Xuelan, et al.
Publicado: (2020)

HAEMATOLOGY IN TROPICAL AREAS: CLINICS IN HAEMATOLOGY
Publicado: (1983)

Haematology /
por: Linch, David C.
Publicado: (1996)

Haematology
por: Cawley, John C
Publicado: (1983)

Hæmatology
Publicado: (1924)

The predictive role of haematological parameters in the diagnosis of osteoarticular brucellosis
por: Balın, Şafak Özer, et al.
Publicado: (2018)

P1570: SARS-COV-2 HUMORAL AND CELLULAR VACCINATION RESPONSE IN PATIENTS WITH LYMPHOID HAEMATOLOGICAL MALIGNANCIES
por: Boerenkamp, L. S., et al.
Publicado: (2022)

Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease
por: Iluta, Sabina, et al.
Publicado: (2022)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
por: Zhang, Wenfa, et al.
Publicado: (2023)

Cardiovascular Risk Factors and Haematological Indexes of Inflammation in Paralympic Athletes with Different Motor Impairments
por: Bernardi, Marco, et al.
Publicado: (2019)

Optimization of Gentisides Extraction from Gentiana rigescens Franch. ex Hemsl. by Response Surface Methodology
por: Chu, Bowen, et al.
Publicado: (2015)

SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense
por: Ju, Xiaohui, et al.
Publicado: (2023)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

B‐cell haematological malignancies and SARS‐CoV‐2 infection: Could immunological interventions influence the outcome?
por: Ochoa‐Grullón, Juliana, et al.
Publicado: (2021)

COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies
por: Passamonti, Francesco, et al.
Publicado: (2021)

P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2.
por: Shaw, B., et al.
Publicado: (2022)

P1536: SARS-COV-2 INFECTIONS IN PATIENTS WITH HAEMATOLOGIC MALIGNANCIES: EFFECT OF VACCINATION AND THE DEVELOPMENT OF HYBRID IMMUNITY
por: Haggenburg, Sabine, et al.
Publicado: (2023)

The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020)

Topological analysis of SARS CoV-2 main protease
por: Estrada, Ernesto
Publicado: (2020)

Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021)

Main Chemotypes of SARS-CoV-2 Reproduction Inhibitors
por: Shiryaev, V. A., et al.
Publicado: (2021)

Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)

Allosteric Hotspots in the Main Protease of SARS-CoV-2
por: Strömich, Léonie, et al.
Publicado: (2022)

Impact of Drug Repurposing on SARS-Cov-2 Main Protease
por: Ndagi, Umar, et al.
Publicado: (2023)

Haematology and immunology /
por: Plowman, P. N.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_qj09i109gm8ca95b7g7m0dj1km